Lidocaine for Thoracentesis
For thoracentesis in adults, use 1% lidocaine (100 mg total dose) administered subcutaneously and along the needle tract, injected 5 minutes before the procedure.
Recommended Dosing Parameters
Based on FDA labeling and clinical evidence, the following approach should be used:
Concentration and Volume
- Concentration: 1% lidocaine solution 11
- Total dose: 100 mg (equivalent to 10 mL of 1% solution) 2
- Maximum safe dose: Do not exceed 4.5 mg/kg (approximately 300 mg total) for infiltration without epinephrine 1
Administration Technique
Inject lidocaine in a stepwise manner:
- Start with subcutaneous infiltration at the skin entry site
- Advance the needle while continuously injecting along the anticipated needle tract
- Include infiltration of the parietal pleura, which is the most pain-sensitive structure
- Wait 5 minutes after injection before performing thoracentesis to allow adequate anesthesia 12
Key Dosing Principles
The FDA label emphasizes that "the lowest concentration and smallest dose that will produce the desired result should be given" 11. Dosages must be reduced for:
- Elderly patients
- Debilitated patients
- Patients with cardiac disease
- Patients with liver disease 1
Alternative Consideration
Lidocaine-prilocaine cream (2.5 g applied over 20-25 cm² for 30 minutes) provides equivalent pain control to infiltrative lidocaine for thoracentesis, though it may increase procedure attempts 2. This is a reasonable alternative for needle-phobic patients, but infiltrative lidocaine remains the standard approach.
Critical Safety Points
Avoid concurrent local anesthetic use: The evidence strongly warns against combining multiple local anesthetic modalities. If using infiltrative lidocaine for thoracentesis, do not administer other regional blocks within 4 hours 3.
Monitor for toxicity: Side effects are directly proportional to total dose injected 11. Use the minimum effective dose, especially in high-risk patients.